Table 1. Cardiovascular Risk Profile (Primary Analysis Population).
Parameter (mean ± SD or %) | Morocco (n = 457) | Global survey (n = 21 050) |
Demographics | ||
Age (years) | 59.1 ± 11.1 | 62.4 ± 11.7 |
Male gender (%) | 40.3 | 52.3 |
BMI (kg/m2) | 28.6 ± 5.8 | 28.9 ± 5.7 |
Hypertension | ||
Duration (years) | 4.6 ± 4.5 | 8.1 ± 7.7 |
SBP (mmHg) | 161.4 ± 27. | 149.2 ± 20.2 |
DBP (mmHg) | 91.1 ± 14.1 | 87.4 ± 11.8 |
Proportion uncontrolled (140/90 mmHg) (%) | 81.4 | 76.8 |
Heart rate/sinus rhythm | ||
Heart rate (bpm) | 74.7 ± 12.3 | 74 ± 12 |
Sinus rhythm: yes (%) | 96.4 | 94.8 |
Cardiovascular risk factors | ||
Family history MI/CAD (%) | 14. 4 | 27.8 |
Regular physical activity (%) | 17.7 | 35.0 |
Current/former smoker (%) | 6.8/5.3 | 14.2/20.5 |
Current diabetics (%) | 19.1 | 27.5 |
Diabetes type 1/type 2 (%) | 11.5/88.5 | 4.9/95.1 |
Duration of diabetes (years) | 6.8 ± 5.5 | 7.9 ± 7.7 |
Additional risk factors | ||
Total cholesterol (mmol/l) | 5.5 ± 1.2 | 5.3 ± 1.1 |
HDL-C (mmol/l) | 1.3 ± 0.5 | 1.3 ± 0.5 |
LDL-C (mmol/l) | 3.0 ± 1.4 | 3.2 ± 1.0 |
Triglycerides (mmol/l) | 1.6 ± 1.0 | 1.8 ± 1.0 |
CRP (mg/dl) | 1.1 ± 0.9 | 0.9 ± 0.9 |
Serum creatinine (mmol/l) | 91.9 ± 26.9 | 89.9 ± 23.8 |
Creatinine clearance (ml/min) | 90.0 ± 35.5 | 87.9 ± 34.1 |
< 30 ml/min (%) | 0 | 0.7 |
30–60 ml/min (%) | 21.3 | 19.3 |
60–80 ml/min (%) | 23.7 | 26.5 |
80–120 ml/min (%) | 36 | 38.8 |
> 120 ml/min (%) | 19 | 14.8 |
Co-morbidities | ||
Coronary artery disease (%) | 10.1 | 22.9 |
Congestive heart failure (%) | 4.4 | 5.8 |
Atrial fibrillation (%) | 4.2 | 8.3 |
History of ischaemic stroke | 8.6 | 4.8 |
History of TIA (%) | 4.4 | 3.8 |
Peripheral artery disease (%) | 3.1 | 4.2 |
Other cardiovascular disease | ||
LVH (indice de Sokolow en mm) | 31.7 ± 9.4 (n = 246) | 24.8 ± 9.8 (n = 8 311) |
Ejection fraction ≤ 40% (%) | 4.9 | 4.7 |
Carotid stenosis (%) | 1.3 | 2.9 |
Aortic aneurysm (%) | 0.4 | 1.4 |
SD: standard deviation, LVH: left ventricular hypertrophy, TIA: transient ischaemic attack, CRP: C-reactive protein, MI: myocardial infarction.